iqvia glp 1 Obesity Deep Dive: How Payer Control Shaped the Market Outlook for Obesity in 2026:

UC Davis Health examines systemic impact of GLP-1based therapies (SACRAMENTO) GLP-1 agonists are reshaping modern health care, delivering benefits that reach far beyond glycemic control and weight loss

Adding medications such as SGLT2 inhibitors may improve glycemic control, support additional weight loss, and enhance cardiovascular outcomes in selected patients

Recent studies have shown that the mammalian gut microbiota is involved in the regulation of bile acid synthesis and metabolism (Jones et al., 2008), and that BAs can be further modified by specific enzymes in the gut microbiota, such as bile salt hydrolase (BSH) and bile acid dehydratase

Curr Top Nutr Res

Nicotinamide adenine dinucleotide: the redox sensor in aging-related disorders